Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

ATOS 0.920 +0.050 (5.75%)
price chart
Atossa Genetics gets bad news from FDA, shares dive
In early Wednesday pre-market trading, shares in Atossa Genetics (NASDAQ: ATOS) had fallen more than 50 percent, dropping $1.23 to $1.10.
Atossa Genetics Inc (NASDAQ:ATOS) To Focus On Commercial Launch Of ...  USMarketsDaily
7 Big Slumps: Atossa Genetics (ATOS), Baxano Surgical (BAXS), Chinanet ...  Markets Emerging
Related articles »  
Atossa Genetics to Present at Upcoming Investor Conferences and Events in ...
SEATTLE, WA--(Marketwired - Nov 25, 2014) - Atossa Genetics Inc. ( NASDAQ : ATOS) today announced that managemen will present at the LD MICRO Main Event VII Conference at the Luxe Sunset, Los Angeles, CA on Tuesday, December 2, 2014 at 12:30 ...
Atossa Genetics Inc. Wins Dismissal of Securities Class Action Litigation
SEATTLE, WA, Oct 31, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -0.99% today announced that the U.S. District Court for the Western District of Washington has granted the defendants' motion to dismiss the amended complaint in the ...
Atossa Beats Claims It Duped Investors In $4M Offering  Law360 (subscription)
Related articles »  
Atossa Genetics Inc. Hires Scott Youmans as Senior Vice President of Operations
SEATTLE, WA, Sep 03, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -1.11% today announced that it has hired Scott Youmans as Senior Vice President of Operations effective September 2, 2014.
Seattle breast cancer test company Atossa Genetics brings on new VP of ...  Puget Sound Business Journal (Seattle) (blog)
Related articles »  
Atossa Genetics gets some good news in Europe
"This approval marks an essential pivot point for Atossa as we pursue commercialization of the ForeCyte Breast Aspirator into various European markets," said Steven Quay, chairman, CEO and president of Atossa, in a statement. Shares in Atossa Genetics ...
Atossa Genetics Receives CE Mark for the ForeCYTE Breast Aspirator Device  Marketwired (press release)
Related articles »  
Atossa Genetics Inc (ATOS): An Expanding Distribution Infrastructure Augurs ...
(Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks.) The shares of Atossa Genetics, Inc. (ATOS) soared 21.0% on September 19th on more than 37-times the normal daily trading volume. At its ...
Atossa Genetics: Room For Further Price Appreciation
Atossa Genetics (NASDAQ:ATOS) is a medical diagnostics company focused on the prevention of breast cancer through the development and commercialization of diagnostic tests which can detect precursors to breast cancer.
Atossa Genetics Inc (ATOS): Atossa Genetics -15% on heels of critical FDA report
Atossa Genetics (ATOS -15.3%) slides sharply after the Food and Drug Administration issues a consumer update on nipple aspirators used for breast cancer screening, saying a mammogram is still the best way to detect breast cancer.
Related articles »  
Atossa Genetics: My Top Biotech Idea For 2013
Analogously, Atossa just announced that it has entered into a contractual agreement with FedMed, Inc., one of the largest proprietary Preferred Provider Organization (PPO) networks in the U.S.
Atossa Genetics Announces Third Quarter 2014 Financial Results and Provides ...
Atossa Genetics Inc. (NASDAQ: ATOS) today announced Third Quarter 2014 financial results and provided an update on recent corporate developments.
Atossa Genetics (ATOS) Announces Quarterly Earnings Results  sleekmoney
Related articles »